ghk cu fda approval injectable GHK-Cu Is GHK-Cu Legal? FDA Approved
Description
A novel HDAC/MIF dual-target inhibitor (6a) at a concentration of 12.5 M promotes apoptosis by inhibiting HDAC activity and inducing histone acetylation (H3K27ac), while simultaneously blocking the MIF-CXCR7-AKT signaling pathway, thereby synergistically inhibiting the survival and proliferation of NSCLC cells (especially EGFR-mutant/TKI-resistant strains)

Convenient and accurate insight into solution-phase equilibria from FlowNMR titrations

, ,

Im already seeing results

It acts as an active form of Vitamin B12 in the body

Richard Nguyen and our experienced medical staff
